Why Is Health Insurance Plan Provider Cigna Stock Trading Higher Today?

Zinger Key Points
  • Cigna Healthcare's fourth quarter adjusted sales increased 17% Y/Y to $13 billion, due to customer growth, higher premiums.
  • Cigna sees a fiscal year 2024 medical cost ratio of 81.7%-82.7%.

Friday, Cigna Corporation CI reported fourth-quarter 2023 sales of $ 51.15 billion, up 12% Y/Y, beating the consensus of $48.89 billion, reflecting strong growth across Evernorth Health Services and Cigna Healthcare.

Cigna Healthcare’s fourth quarter adjusted sales increased 17% Y/Y to $13 billion, reflecting customer growth and premium rate increases to cover underlying medical cost trends.

Cigna’s medical cost ratio – or spending on claims as a percentage of premiums – was 82.2% compared to 83.8% a year ago, benefitting from strong performance in the U.S. Healthcare business, including affordability initiatives, effective pricing execution, and favorable stop loss results.

Total premiums during the quarter rose 17% to $11.18 billion. 

Also Read: Cigna’s Medicare Business Sale: Health Care Service Could Scoop The Business.

The total number of medical customers grew 10% from December 31, 2022, to 19.78 million, primarily driven by growth in U.S. Healthcare, including fee-based customers, Individual and Family Plans, and Medicare Advantage customers.

Total pharmacy customers increased 5% to 98.57 million.

Revenue from Cigna’s Evernorth unit, engaged in the pharmacy benefit management business, rose 12% to $40.52 billion, reflecting strong organic growth in specialty pharmacy and care solutions.

The adjusted EPS of $6.79, up from $5.02 a year ago, beat the Wall Street estimate of $6.53.

Cigna declared a cash quarterly dividend of $1.40 per share to be paid on March 21, 2024, to shareholders of record as of the close of trading on March 6, 2024. This reflects a 14% increase from the 2023 cash quarterly dividend of $1.23 per share.

Guidance: Cigna forecasts fiscal year 2024 revenues of at least $235 billion and adjusted EPS of at least $28.25 versus consensus of $229.24 billion and $28.26, respectively.

For fiscal year 2024, the company expects around 19.3 million medical customers.

Cigna sees a fiscal year 2024 medical cost ratio of 81.7%-82.7%.

Price Action: CI shares are up 4.16% at $320.11 during the premarket session on the last check Friday.

Photo via Wikimedia Commons

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!